The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome 

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization  Martin D. Keltz,
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial  Renato Seracchioli, M.D., Mohamed.
Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 
Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial  Tasuku Harada,
Male contraception Fertility and Sterility
Akanksha Mehta, M.D., Mark Sigman, M.D.  Fertility and Sterility 
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michael M. Alper, M.D.  Fertility and Sterility 
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
Hepatitis and reproduction
Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome 
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system  Shan Liu, M.D.,
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.
Lauren Groskaufmanis, M.P.H., Saba W. Masho, M.D. 
Medical treatment of ectopic pregnancy: a committee opinion
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
Oocyte cryopreservation
Evolutionary determinants of polycystic ovary syndrome: part 1
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS)  F. Gonzalez,
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Introduction Fertility and Sterility
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Increased secretion of amylin in women with polycystic ovary syndrome
The forgotten coil Fertility and Sterility
Prevalence of polycystic ovary syndrome in adolescents
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial  Renato Seracchioli, M.D., Mohamed.
A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause 
Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D.  Fertility and Sterility 
An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome  Mehmet Gungor Kaya, M.D., Ozgur Gunebakmaz, M.D.,
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Website quality assessment: Mistaking apples for oranges
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Manuel Maliqueo, Ph. D. , Bárbara Echiburú, Ph. D
Karen L. Margolis, M. D. , Hans-Olov Adami, M. D. , Juhua Luo, M. S
Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate–resistant polycystic ovary.
Fertility and Sterility: an evaluation
Paolo Moghetti, M.D.  Fertility and Sterility 
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Current evaluation of amenorrhea
A simplified novel laparoscopic formation of neovagina for cases of Mayer-Rokitansky- Küster-Hauser syndrome  Atef Mohammad Darwish, M.D.  Fertility and.
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa  Orit Pinhas-Hamiel, M.D., Nurit Pilpel,
In vitro sildenafil citrate use as a sperm motility stimulant
Daniel R. Grow, M.D., Khosro Iromloo, M.D.  Fertility and Sterility 
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels 
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
Presentation transcript:

The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome  Nevin Sağsöz, M.D., Zerrin Orbak, M.D., Volkan Noyan, M.D., Aykan Yücel, M.D., Banu Uçar, M.D., Leyla Yıldız, M.D.  Fertility and Sterility  Volume 92, Issue 2, Pages 660-666 (August 2009) DOI: 10.1016/j.fertnstert.2008.07.008 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Correlation between ghrelin levels and free testosterone before EE and DRSP therapy and after EE and DRSP therapy. Fertility and Sterility 2009 92, 660-666DOI: (10.1016/j.fertnstert.2008.07.008) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Changes in leptin levels after EE and DRSP therapy. Fertility and Sterility 2009 92, 660-666DOI: (10.1016/j.fertnstert.2008.07.008) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Changes in ghrelin levels after EE and DRSP therapy. Fertility and Sterility 2009 92, 660-666DOI: (10.1016/j.fertnstert.2008.07.008) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.